Levetiracetam
NDC 51224-013, levetiracetam, injection, solution, concentrate, from TAGI Pharma, Inc..
- Product NDC
- 51224-013
- Status
- Listed
- Labeler
- TAGI Pharma, Inc.
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209781
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51224-013 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVETIRACETAM100 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/72f7ddd9-1b2c-4e26-8060-20e10c1c5d1c
Use it
Look up 51224-013 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51224-013 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51224-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.